Abstract: Cell-cell fusion is an important natural and engineered process for in-depth studies into hybridomas, developmental biology, immunology and various cellular therapies. It is also a powerful tool for analysis of gene expression, chromosomal mapping, antibody production, cloning mammals, and cancer immunotherapy. However, research so far has primarily focused on cell models such as C.elegans, drosophila, myoblasts, spleen-myeloma cell hybrids and various plant protoplasts. Rhabdomyosarcoma cells are a rare form of musculoskeletal cancer cells found in the head, neck, and other less skeletal areas of the human cancer patient's body. As these cells do not normally undergo fusion naturally, they are an interesting model for studying cell fusion. Among all the techniques for fusion, electrofusion (or electroporation) can be applied to a wide range of cell types with high efficiency and high post-fusion viability. By coupling these cells with this technique, the effectson cell proliferation, growth pattern, and hybridoma count wereinvestigated. Overall, the experimental results showed that an adequate electrical stimulation helped to facilitate the fusion and proliferation of the RD cells. Furthermore,a DC current produced the highest number of hybridomas, while maintaining the highest proliferation rate.After subtracting for the control samples, an average fusion yield of 24% was obtained under this DC setting, which is comparable to the fusion yield of 20% obtained using the same technique by other researchers. This is a promising result for its application in the production of monoclonal antibodies for cancer research and treatment.
Introduction
Cell-cell fusion is an important natural and engineered process for in-depth studies into hybridomas, immunology and various human cellular therapies. [1] [2] However, so far the work done has been mostly on C.elegans, drosophila, myoblasts, spleen-myeloma cell hybrids and various plant protoplasts. Rhabdomyosarcoma (RD) cells, of 20-40µm dimension, are a rare form of musculoskeletal cancer cells found in the head, neck, and other less skeletal areas of the human cancer patient's body. As fusion of these cells is not a natural and automatic process, engineering it artificially via specially-designed chip-based microfluidic technologies is expected to be an effective tool that can be extended for other similar cell types.
Materials and Methods
A simplified one-dimensional cell fusion model ( Fig. 1 ) was created to model the highly complicated structure of a lipid bilayer cell membrane, based on the spherical morphology of the cells displayed during the trypsinization stage. This model is accurate for this study and is applicable for an infinite number of cells of different sizes. From this model, an electrofusion model ( Fig. 2) was derived. In a typical electroporative process, an applied electrical field produces a current through the cell suspension. As the cell membrane is composed of lipid bilayer with extremely low electrical conductance, the effective current passing through the solution is a direct function of the applied voltage. When the voltage is lower than the electroporation voltage, no current flows through the cell. As the voltage increases, reversible electroporation of the cell is expected and micro-aqueous pores start to form in the cell membrane. These micro-aqueous pores yield a dramatic increase in membrane conductance, thus measurable currents can flow through the cell membrane. When the voltage exceeds a certain critical value, also known as the transmembrane voltage, irreversible electroporation is triggered, which leads to the degeneration of cell membrane and a fusion of the two adjacent membranes. The behavior of this electrofusion process that of a non-linear resistor and capacitor connected in parallel, with the cells of zero resistance as shown in Fig. 2 . The key considerations in a new electrofusion design was (1) transparency (can be viewed from all directions), (2) sterility (no cross-contamination) and (3) flexibility to add an electrical conductor to the device. To fulfill requirement (2), it was thought best to control the electrical current from the outside of the cell culture, so as to avoid direct contact with the cells. The end design result is shown by the three images in Fig. 3(a)-(c) .From a common T75 parent flask, cells were passaged into three T25 flasks through the addition of 0.05% Trypsin-EDTA. Once the cells have transitioned from a suspension to a quiescence state after being incubated for 4 h in Minimum Essential Medium in 5% CO 2 at 37 o C, electroporation was done on the designs (Fig. 3) to produce the results for (a) Control, (b) DC and (c) AC (Fig. 4) . By counting the number of live cells before and after the electrofusion, a formula shown in Eq. 1 was used to calculate the Proliferation Rate. The advantage of counting only the cells that survive is that only the cells useful for obtaining hybridsfor monoclonal antibody productionare counted.
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!" (1) and based on the paper by Trontelj et al (2008) [3] , the Fusion Yield would be determined by Eq. 2.
All the cells were counted using a standard Neubauer hemocytometer. Fig. 4 show greater confluency in the DC than the AC and Control after 24 h. Table 1 and Table 2 summarize the two best of three experimental results. 
Results

The images shown in
Discussion and Conclusion
Overall, the experimental results showed that an adequate electrical stimulation helped to facilitate the fusion and proliferation of the RD cells. The cells also had a tendency to grow near the electrodes.On analysis, the results showed that the proliferation rate was notably higher in Experiment 1 than in Experiment 2, possibly proving that an initial cell population of close to 40,000 before the experiment is more optimal than a higher cell population of near 100,000. It is also evident that under the DC setup, the proliferation rate and fusion yield were higher thanthe ACsetup andcontrol, highlighting both itssafety and efficiency.After subtraction of the multinucleated cells in the control samples, the fusion yield under the DC setup for Experiment 1 and Experiment 2 were 23% and 25% respectively, thus averaging at 24%. Even though simple and limited resources were used in this study, this value is comparable tothe fusion yield of 20% obtained by Trontelj et al (pp.128) [3] andalso that byother researchers [4] [5] [6] using the same technique. This is a very promising result foran application in the antibody industry. The future work arising from this study involves exploring advanced designsto further enhance thefusion yield and subsequently speed up antibody manufacturing,possibly through a portable, versatile and reproducible lab-on-a-chip.
